Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of a steroid-free and
calcineurin-inhibitor free treatment regimen for patients who are receiving a kidney
transplant from a living donor that is HLA-identical (has a similar immune system).